NuCana Granted U.S. Patent #11925658 Today For "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance". Broad Patent For Leukemia, Prostate, Lung, And Breast Cancers.

Benzinga · 03/12 20:00